On Jan 5, 2022 Protai closed a Seed round and raised $8,000,000 from Grove Ventures, Pitango Venture Capital, featuring lead investors Grove Ventures, Pitango Venture Capital.

About the company: Protai is located at Israel, Asia.
“Protai is driving drug discovery and development by comprehensively mapping the course of a disease on the protein level, unmasking deep cellular function to improve the way new drugs are developed.”

Company website: http://www.protai.bio